Clinical Trial Update: Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 [NA]

View source ↗

Summary

The ANDROMEDA-SHOCK-2 trial evaluating hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Intensive Care Unit Acquired Weakness, Shock, Septic | NA | Status: RECRUITING